TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T03995 XX ID T03995 XX DT 07.11.2000 (created); dkl. DT 14.06.2006 (updated); kau. CO Copyright (C), QIAGEN. XX FA SRF-M XX SY SRF (440 AA); SRF-M. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G002018 Srf. XX CL C0014; MADS. XX SZ 440 AA; 44.6 kDa (cDNA) (calc.). XX SQ MLPSQAGAAAALGRGSALGGNLNRTPTGRPGGGGGTRGANGGRVPGNGAGLGQSRLEREA SQ AAAAAPTAGALYSGSEGDSESGEEEELGAERRGLKRSLSEMELGVVVGGPEAAAAAAGGY SQ GPVSGAVSGAKPGKKTRGRVKIKMEFIDNKLRRYTTFSKRKTGIMKKAYELSTLTGTQVL SQ LLVASETGHVYTFATRKLQPMITSETGKALIQTCLNSPDSPPRSDPTTDQRMSATGFEEP SQ DLTYQVSESDSSGETKDTLKPAFTVTNLPGTTSTIQTAPSTSTTMQVSSGPSFPITNYLA SQ PVSASVSPSAVSSANGTVLKSTGSGPVSSGGLMQLPTSFTLMPGGAVAQQVPVQAIHVHQ SQ APQQASPSRDSSTDLTQTSSSGTGGVPQVFLTAPSGTVQIPVSAVQLHQMAVIGQQAGSS SQ SNLTELQVVNLDATHSTKSE XX SC Sequence taken from Ref. [1] XX FT 137 196 SM00432; MADS. FT 137 197 PS50066; MADS_BOX_2. FT 143 437 PF00478; IMP dehydrogenase / GMP reductase domain. FT 145 195 PF00319; SRF-type transcription factor (DNA-binding a. XX SF full length cDNA clone is T00765; SF exon 5 is missing [1]; SF in alternative splice variant T03996 exons 4 and 5 are missing, in T03997 exons 3, 4 and 5 are missing [1]; SF binding DNA as homodimer [2]; SF heterodimerization with C-terminal truncated SRF [2]; XX CP Embryo:E9,E10,E13,E14 [1];adult: testis, liver, kidney, lung, uterus, aorta, heart, skeletal muscle [1]; brain, heart [2]; C2C12 un- and differentiated myoblasts, myotubes [1]; rat VSMC [1]; protein level: P19 cells, C2C12 myoblasts [1] [1] [2]. CN adult: liver, kidney, spleen, stomach [2]. XX FF inhibition of SRE-dependent promoter activity of cardiac alpha-actin promoter, skeletal alpha-actin promoter, SM22 alpha promoter and smooth alpha actin promoter [2]; FF repression of serum-induced activity of c-fos-SRE [2]; XX MX M00152 V$SRF_01. MX M01257 V$SRF_02. MX M00215 V$SRF_C. MX M07618 V$SRF_Q3. MX M00810 V$SRF_Q4. MX M00922 V$SRF_Q5_01. MX M01007 V$SRF_Q5_02. MX M00186 V$SRF_Q6. XX BS R09532. XX DR TRANSPATH: MO000027905. DR EMBL: AB038376; XX RN [1]; RE0015274. RX PUBMED: 10642500. RA Kemp P. R., Metcalfe J. C. RT Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity RL Biochem. J. 345:445-451 (2000). RN [2]; RE0015300. RX PUBMED: 10373507. RA Belaguli N. S., Zhou W., Trinh T. H., Majesky M. W., Schwartz R. J. RT Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets RL Mol. Cell. Biol. 19:4582-4591 (1999). XX //